Oral Antibiotic Treatment Options for Acne Vulgaris
- PMID: 33133338
- PMCID: PMC7577330
Oral Antibiotic Treatment Options for Acne Vulgaris
Abstract
Acne vulgaris is the most common dermatological disease in the United States, affecting up to 85 percent of teenagers. While the American Academy of Dermatology has established guidelines regarding acne treatment in general, the variability among acne treatments, even within a given class, prevents establishment of a straightforward regimen. For example, moderate to severe acne is generally treated with an oral antibiotic, although several options are available-both across and within antibiotic classes. The aim of this review is to report the efficacy and safety data available for commonly prescribed oral antibiotics. While there are currently no data to support superiority of one drug over another, there are substantial differences in safety profiles and brand-specific features that may make one antibiotic preferable over another.
Keywords: antibiotic resistance; azithromycin; doxycycline; minocycline; sarecycline.
Copyright © 2020. Matrix Medical Communications. All rights reserved.
Conflict of interest statement
FUNDING:The development of this article was supported by an unrestricted grant from Journey Medical Corporation. DISCLOSURES:Dr. Baldwin serves on the speaker’s bureau, consults for, and/or attends medical advisory boards for Almirall, Galderma, Valeant Pharmaceuticals, Sun Pharmaceutical, Mayne Pharma, EPI Health, and Journey Medical Corporation.
Similar articles
-
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.Front Microbiol. 2022 May 31;13:901911. doi: 10.3389/fmicb.2022.901911. eCollection 2022. Front Microbiol. 2022. PMID: 35711781 Free PMC article.
-
Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.J Drugs Dermatol. 2018 Mar 1;17(3):333-338. J Drugs Dermatol. 2018. PMID: 29537451 Clinical Trial.
-
SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology.J Clin Aesthet Dermatol. 2020 Oct;13(10):45-48. Epub 2020 Oct 1. J Clin Aesthet Dermatol. 2020. PMID: 33584958 Free PMC article. Review.
-
Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016.J Drugs Dermatol. 2023 Mar 1;22(3):265-270. doi: 10.36849/JDD.7345. J Drugs Dermatol. 2023. PMID: 36877883
-
Oral Antibacterial Therapy for Acne Vulgaris: An Evidence-Based Review.Am J Clin Dermatol. 2017 Aug;18(4):469-490. doi: 10.1007/s40257-017-0267-z. Am J Clin Dermatol. 2017. PMID: 28255924 Review.
Cited by
-
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.Front Microbiol. 2022 May 31;13:901911. doi: 10.3389/fmicb.2022.901911. eCollection 2022. Front Microbiol. 2022. PMID: 35711781 Free PMC article.
-
Associations between Polycystic Ovary Syndrome (PCOS) and Antibiotic Use: Results from the UAEHFS.Antibiotics (Basel). 2024 Apr 26;13(5):397. doi: 10.3390/antibiotics13050397. Antibiotics (Basel). 2024. PMID: 38786126 Free PMC article.
-
Acceptability and feasibility of pre-exposure prophylaxis for bacterial STIs: a systematic review.PLoS One. 2025 Feb 6;20(2):e0317669. doi: 10.1371/journal.pone.0317669. eCollection 2025. PLoS One. 2025. PMID: 39913625 Free PMC article.
-
Evaluation of the antibacterial efficacy of combinations of Garcinia mangostana, Curcuma comosa, and Acanthus ebracteatus for acne vulgaris treatment: in Silico and in vitro validation.BMC Complement Med Ther. 2025 Jul 10;25(1):256. doi: 10.1186/s12906-025-04997-6. BMC Complement Med Ther. 2025. PMID: 40640786 Free PMC article.
-
Topical Administration of Lactiplantibacillus plantarum (SkinDuoTM) Serum Improves Anti-Acne Properties.Microorganisms. 2023 Feb 7;11(2):417. doi: 10.3390/microorganisms11020417. Microorganisms. 2023. PMID: 36838382 Free PMC article.
References
-
- Eichenfield LF, Krakowski AC, Piggott C et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013;131:S163–S186. - PubMed
-
- Thiboutot DM, Dreno B, Abanmi A et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78:S1–S23. - PubMed
-
- Marson JW, Baldwin HE. An overview of acne therapy, Part 1: Topical therapy, oral antibiotics, laser and light therapy, and dietary interventions. Dermatol Clin. 2019;37(2):183–193. - PubMed
-
- Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 201674:945–73. - PubMed
-
- Halvsorsen JA, Stern RS, Dalgard F et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acn a population-based study. J Invest Dermatol. 2011;131(2):363–370. - PubMed
Publication types
LinkOut - more resources
Full Text Sources